Blog

Mark E. Cooper

Nov 21, 2024, 16:00

Mark E. Cooper will be joining SCRI to help coordinate a comprehensive breast program

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research Institute, reshared a post by Mark E. Cooper on LinkedIn, adding:

“We are so happy to have Mark E. Cooper, MD, FACS at SCRI Oncology Partners.

I have seen his dedication to his patients and his fantastic surgical outcomes in breast cancer for years and we are so excited to have him on *OUR* team!”

Quoting Mark E. Cooper‘s post:

“After 30 years of practicing surgery and helping found The Surgical Clinic, I will be joining Sarah Cannon Research Institute (SCRI) where I will help coordinate a comprehensive breast program encompassing benign and malignant breast disease. I will be concentrating solely on breast disease. This is an exciting time, not only for me, but patients as well. My dedication to patients will not change. I will continue to offer the same services, just in a different location. As of December 14, 2024 my new location will be

Sarah Cannon Research Institute
335 24th Ave. North, Suite 200
Nashville, TN 37203
615-329-7640

I look forward to this opportunity as I turn the page on a new chapter in my life.”

Erika Hamilton is a medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research Institute (USA). Dr. Hamilton is a past chair of ASCO’s Scientific Breast Committee ’21-’22, participant of the ASCO Leadership Development Program, Associate Editor for Clinical Breast Cancer, co-chair for Great Debates and Updates in Women’s Oncology Conference and a board member of the Susan G. Komen Foundation of Central Tennessee. She is active in the community, volunteering with Gilda’s Club Middle Tennessee, the American Cancer Society’s Hope Lodge, Ovarcome ovarian cancer support organization, Brentwood Baptist Church and the Susan G. Komen Race for the Cure.